Cancer cell–induced neutrophil extracellular traps promote both hypercoagulability and cancer progression

Abstract

Our findings indicate that cancer cell-induced NET formation enhances both hypercoagulability and cancer progression and suggest that inhibitors of NET formation such as PGE1 and antithrombin can be potential therapeutics to reduce both hypercoagulability and cancer progression.